Concepedia

Doris Hui Ying Tee

DH

Statistics

Publications

6

Citations

171

H-Index

6

Active since

2012

Affiliations

Agency for Science, Technology and Research(Current)

Experimental Drug Development Centre

BOKU University

Bioprocessing Technology Institute

Doris Hui Ying Tee is an author at Agency for Science, Technology and Research specializing in pharmacy, drug discovery, and medicinal chemistry.

Publications per year

2012–2021

6

Publications

6

Strategic Design of Catalytic Lysine‐Targeting Reversible Covalent BCR‐ABL Inhibitors**

David Quach, Guanghui Tang, Jothi Anantharajan et al. · Angewandte Chemie International Edition · 2021 · 78 citations

, , +16

Fragment-Based Drug Discovery of Potent Protein Kinase C Iota Inhibitors

Jacek Kwiatkowski, Doris Hui Ying Tee, Guoying Chen et al. · Journal of Medicinal Chemistry · 2018 · 26 citations · Full text

, , +17

Liquid Formulations for Stabilizing IgMs During Physical Stress and Long-Term Storage

Monika Mueller, Maybelle Q. T. Loh, Rupert Tscheließnig et al. · Pharmaceutical Research · 2012 · 22 citations

, , +13

Liquid Formulations for Long-Term Storage of Monoclonal IgGs

Monika Mueller, Maybelle Q. T. Loh, Doris Hui Ying Tee et al. · Applied Biochemistry and Biotechnology · 2013 · 20 citations

, , +12

Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors

Pearly Shuyi Ng, Klement Foo, Sandra Phek Lin Sim et al. · Bioorganic & Medicinal Chemistry · 2021 · 13 citations · Full text

, , +16

1–5 of 6